DROSPIRENONE

Search structure
Trade Names:
Synonyms:
Status: Approved (2001)
Entry Type: Small molecule
Molecule Category: Parent
ATC: G03AC10
UNII: N295J34A25

Structure
InChI Key METQSPRSQINEEU-HXCATZOESA-N
Smile C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C
InChI
InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H30O3
Molecular Weight 366.5
AlogP 4.31
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 0.0
Polar Surface Area 43.37
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 27.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Mineralocorticoid receptor antagonist PubMed DailyMed
Primary Target
Mineralocorticoid receptor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Transporter Primary active transporter ATP-binding cassette ABCB subfamily
- 16400 - - -
Transporter Primary active transporter ATP-binding cassette ABCC subfamily
- 37900 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dysmenorrhea 3 D004412 ClinicalTrials
Polycystic Ovary Syndrome 3 D011085 ClinicalTrials
Bulimia 2 D002032 ClinicalTrials
Depressive Disorder 2 D003866 ClinicalTrials
Premenstrual Syndrome 2 D011293 ClinicalTrials
Hidradenitis Suppurativa 2 D017497 ClinicalTrials
Bulimia Nervosa 2 D052018 ClinicalTrials

Related Entries

Scaffolds

Mixture
Mixture
Mixture

Cross References

Resources Reference
CAS NUMBER 67392-87-4
ChEBI 50838
ChEMBL CHEMBL1509
DrugBank DB01395
DrugCentral 968
EPA CompTox DTXSID7046465
FDA SRS N295J34A25
Human Metabolome Database HMDB0015467
Guide to Pharmacology 2874
PharmGKB PA164749409
PubChem 68873
SureChEMBL SCHEMBL153316
ZINC ZINC000003927200
CONTENTS